Budget Impact Analysis of Using Pazopanib-Everolimus in First and Second Line of Treatment, In Patients with Metastatic Renal Cell Carcinoma

Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.2135
https://www.valueinhealthjournal.com/article/S1098-3015(16)33501-X/fulltext
Title : Budget Impact Analysis of Using Pazopanib-Everolimus in First and Second Line of Treatment, In Patients with Metastatic Renal Cell Carcinoma
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)33501-X&doi=10.1016/j.jval.2016.09.2135
First page : A719
Section Title : Disease-Specific Studies
Open access? : No
Section Order : 2025
Categories :
Tags :
Regions :
ViH Article Tags :